- Home
- Featured Publications
- Center Publications
- Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
Citation | “Serum Uromodulin Predicts Less Coronary Artery Calcification And Diabetic Kidney Disease Over 12 Years In Adults With Type 1 Diabetes: The Cacti Study.”. Diabetes Care, pp. 297-302. . |
Center | University of Colorado Denver |
Author | Petter Bjornstad, Pattara Wiromrat, Richard J Johnson, Rachel Sippl, David Z I Cherney, Randy Wong, Marian J Rewers, Janet K Snell-Bergeon |
Abstract |
OBJECTIVE: Novel biomarkers are needed to better predict coronary artery calcification (CAC), a marker of subclinical atherosclerosis, and diabetic kidney disease (DKD) in type 1 diabetes. We evaluated the associations between serum uromodulin (SUMOD [a biomarker associated with anti-inflammatory and renal protective properties]), CAC progression, and DKD development over 12 years. RESEARCH DESIGN AND METHODS: Participants ( = 527, 53% females) in the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study were examined during 2002-2004, at a mean age of 39.6 ± 9.0 years and a median duration of diabetes of 24.8 years. Urine albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) determined by the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) creatinine equation were measured at baseline and after a mean follow-up period of 12.1 ± 1.5 years. Elevated albumin excretion was defined as ACR ≥30 mg/g, rapid GFR decline (>3 mL/min/1.73 m/year), and impaired GFR as eGFR <60 mL/min/1.73 m. SUMOD was measured on stored baseline plasma samples (Meso Scale Discovery). CAC was measured using electron beam computed tomography. CAC progression was defined as a change in the square root-transformed CAC volume of ≥2.5. RESULTS: Higher baseline SUMOD level conferred lower odds of CAC progression (odds ratio 0.68; 95% CI 0.48-0.97), incident elevated albumin excretion (0.37; 0.16-0.86), rapid GFR decline (0.56; 0.35-0.91), and impaired GFR (0.44; 0.24-0.83) per 1 SD increase in SUMOD (68.44 ng/mL) after adjustment for baseline age, sex, systolic blood pressure, LDL cholesterol, and albuminuria/GFR. The addition of SUMOD to models with traditional risk factors also significantly improved the prediction performance for CAC progression and incident DKD. CONCLUSIONS: Higher baseline SUMOD level predicted lower odds of both CAC progression and incident DKD over 12 years in adults with type 1 diabetes. |
Year of Publication |
2019
|
Journal |
Diabetes care
|
Volume |
42
|
Issue |
2
|
Number of Pages |
297-302
|
Date Published |
12/2019
|
ISSN Number |
1935-5548
|
DOI |
10.2337/dc18-1527
|
Alternate Journal |
Diabetes Care
|
PMID |
30482755
|
PMCID |
PMC6341281
|
Download citation |